Ulcerative colitis is a chronic, immune-mediated disorder of the colon, which is characterised by a relapsing–remitting course. Owing to the growing understanding of the immunopathogenesis of this ...

Ulcerative colitis (UC) is one of the most common inflammatory bowel diseases, a lifelong condition that can cause chronic ...

A significantly higher percentage of patients who received tulisokibart had clinical remission than those who received placebo (26% vs 1%). (HealthDay News) — Tulisokibart, a tumor necrosis ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

Ulcerative colitis is a chronic condition characterized by inflammation and ulcers in the colon. Research is ongoing to expand treatment options. A study published in the New England Journal of ...

NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) announced today the completion of patient enrollment in the Phase 2b clinical ...

A new LOCAL online community built for you. Click now to see all the available groups. More than a quarter of people who got the treatment, called tulisokibart, went into remission FRIDAY, Sept. 27, ...

A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a ...

Crohn's disease and ulcerative colitis are complex diseases that have required the use of multiple modalities to aid in treatment. With an increasing understanding of the underlying pathogenetic ...

The discovery that a toxin made by bacteria found in dirty water might help trigger ulcerative colitis could lead to new ...

Market opportunities in the IBD treatment sector include the rising demand for targeted therapies and biologics due to a deeper understanding of the disease, alongside the expansion of biosimilar ...